BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 954 filers reported holding BAXTER INTL INC in Q1 2014. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $291,000 | -16.6% | 4,401 | -2.4% | 0.12% | +2.7% |
| Q3 2018 | $349,000 | +10.4% | 4,511 | +5.6% | 0.11% | +5.7% |
| Q2 2018 | $316,000 | +17.0% | 4,271 | +1.1% | 0.11% | +21.8% |
| Q1 2018 | $270,000 | +17.9% | 4,224 | +19.0% | 0.09% | +35.9% |
| Q4 2017 | $229,000 | -4.6% | 3,550 | -7.0% | 0.06% | -8.6% |
| Q3 2017 | $240,000 | -40.6% | 3,819 | -42.8% | 0.07% | -40.7% |
| Q2 2017 | $404,000 | -84.1% | 6,679 | -89.2% | 0.12% | -86.9% |
| Q1 2016 | $2,536,000 | -13.6% | 61,740 | +47.1% | 0.90% | -8.5% |
| Q2 2015 | $2,936,000 | -4.6% | 41,980 | -6.6% | 0.98% | +1.4% |
| Q1 2015 | $3,079,000 | +1.8% | 44,947 | +8.9% | 0.97% | +1.2% |
| Q4 2014 | $3,024,000 | +15.9% | 41,259 | +13.4% | 0.96% | +33.0% |
| Q3 2014 | $2,610,000 | +32.2% | 36,368 | +33.2% | 0.72% | +55.6% |
| Q2 2014 | $1,974,000 | -35.1% | 27,297 | -34.0% | 0.46% | +25.9% |
| Q1 2014 | $3,040,000 | – | 41,372 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
| GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
| Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
| Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
| Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
| Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
| TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
| CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
| Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
| Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |